1 |
Lin B, Ma J, Fang Y, Lei P, Wang L, Qu L, Wu W, Jin L, Sun D. Advances in Zebrafish for Diabetes Mellitus with Wound Model. Bioengineering 2023;10:330. [DOI: 10.3390/bioengineering10030330] [Reference Citation Analysis]
|
2 |
Yu M, Cao R, Ma Z, Zhu M. Development of "smart" drug delivery systems for chemo/PDT synergistic treatment. J Mater Chem B 2023;11:1416-33. [PMID: 36734612 DOI: 10.1039/d2tb02248f] [Reference Citation Analysis]
|
3 |
Chen H, Lei P, Ji H, Yang Q, Peng B, Ma J, Fang Y, Qu L, Li H, Wu W, Jin L, Sun D. Advances in Escherichia coli Nissle 1917 as a customizable drug delivery system for disease treatment and diagnosis strategies. Mater Today Bio 2023;18:100543. [PMID: 36647536 DOI: 10.1016/j.mtbio.2023.100543] [Reference Citation Analysis]
|
4 |
Sha X, Dai Y, Chong L, Wei M, Xing M, Zhang C, Li J. Pro-efferocytic macrophage membrane biomimetic nanoparticles for the synergistic treatment of atherosclerosis via competition effect. J Nanobiotechnology 2022;20:506. [PMID: 36456996 DOI: 10.1186/s12951-022-01720-2] [Reference Citation Analysis]
|
5 |
Xu H, Li S, Liu YS. Nanoparticles in the diagnosis and treatment of vascular aging and related diseases. Signal Transduct Target Ther 2022;7:231. [PMID: 35817770 DOI: 10.1038/s41392-022-01082-z] [Reference Citation Analysis]
|
6 |
Dabravolski SA, Khotina VA, Sukhorukov VN, Kalmykov VA, Mikhaleva LM, Orekhov AN. The Role of Mitochondrial DNA Mutations in Cardiovascular Diseases. Int J Mol Sci 2022;23:952. [PMID: 35055137 DOI: 10.3390/ijms23020952] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
|
7 |
El Hadri K, Smith R, Duplus E, El Amri C. Inflammation, Oxidative Stress, Senescence in Atherosclerosis: Thioredoxine-1 as an Emerging Therapeutic Target. Int J Mol Sci 2021;23:77. [PMID: 35008500 DOI: 10.3390/ijms23010077] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|